boiled peanut oral immunotherapy

Boiled peanut oral immunotherapy (BPOIT) is an investigational, non-commercial food-based immunotherapy designed to treat IgE-mediated peanut allergy in children. The approach utilizes the reduced allergenicity of boiled peanuts, where thermal processing (boiling) alters the protein structure of major allergens like Ara h 1, 2, and 3, making them less reactive while maintaining their ability to induce immune tolerance. The therapy involves a sequential up-dosing protocol, starting with boiled peanuts and eventually transitioning to roasted peanuts, with the goal of achieving desensitization. Clinical trials, primarily led by Professor Dianne E. Campbell in Australia, have demonstrated that this method is effective in approximately 80% of participants and offers a potentially safer alternative to traditional oral immunotherapy using roasted peanut flour.

Other names

BPOITboiled peanut immunotherapy